Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-111-0 | CAS number: 64742-11-6 A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
A key mouse lymphoma assay (OECD 476) was identified, in which the DAE sample tested positive. In contrast, two in vivo micronucleus tests (OECD 475) were identified that showed negative results in rats that were exposed either dermally or orally.
Two positive read-across studies for in vitro gene mutation in bacteria (OECD 471) were identified.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
Additional information from genetic toxicity in vitro:
The following read-across in vitro genetic toxicity studies were identified for bacterial mutation assays. A modification to the Ames reverse mutation assay was developed as an adaptation to improve sensitivity to complex hydrocarbon mixtures produced by the refining of petroleum. Modifications included extraction of the oil samples with dimethyl sulphoxide to produce aqueous-compatible solutions that more easily interact with the bacteria and use of only one bacterial tester strain (TA98) most susceptible to poly aromatic hydrocarbon induced mutagenesis (Blackburn et al., 1984). The procedure was further modified by preliminary solubilisation of the oil in cyclohexane, substitution of Aroclor 1254-induced hamster liver S-9 for rat S-9, and an increase in the concentrations of both the NADP co-factor and S-9 homogenate levels (Blackburn et al., 1986). In the Blackburn et al. study (1986), S. typhimurium strain TA 98 was exposed to six DMSO-extracted oil samples (heavy paraffinic distillate, light paraffinic distillate, three separate samples of heavy naphthenic distillate, and heavy naphthenic distillate blend) in the presence of Aroclor 1254-induced hamster liver S9 fraction. All of the test substances showed mutagenicity indices ranging from 4.1 to 10. Base oils with an MI between 1 and 2 may or may not be mutagenic whereas oils with an MI > 2.0 are considered to be potentially mutagenic. As all of the unrefined oils had MI values > 2.0, they are all considered to be potentially mutagenic in vitro.
One key mouse lymphoma assay was identified. In this study, L5178Y cells cultured in vitro were exposed to light paraffinic distillate solvent extract in ethanol at concentrations of 25, 50, 75, 100, 150 and 200µL/mL without activation and at 12.5, 25, 50, 75, 100 and 150µL/mL with activation (API, 1986c).
In the absence of metabolic activation, a dose-response relationship was observed from 75 µL/mL to 200 µL/mL DAE with decreasing relative growth percentages (i.e., 119.7% to 2.2%), decreasing viable colonies (i.e., 661 to 89), and increasing mutant frequency (in 10E-6 units). The minimum criterion for mutagenesis in this assay was a mutant frequency exceeding 67.9x10-6. Concentrations of 150 µL/mL and 200 µL/mL induced mutant frequencies that exceeded the minimum criterion. Hence the tested material was considered mutagenic without activation. In the presence of metabolic activation, a dose-response relationship was observed from 75 µL/mL to 150 µL/mL DAE with decreasing relative growth percentages and increasing mutant frequency (in 10E-6 units). The minimum criterion for mutagenesis in this assay was a mutant frequency exceeding 73.5x10-6. Treatments from 25 mL/mL to 150 mL/mL induced increases in the mutant frequency, which ranged from 1.8-fold to 3.2-fold above the minimum criterion.
There was a general trend toward higher mutant frequencies at higher concentrations of the test material. The tested material was therefore considered mutagenic with activation. Light paraffinic distillate solvent extract is therefore mutagenic with and without activation under the conditions specified in this assay.
Two in vivo micronucleus tests also were identified. In one study, rats were dermally exposed to 30, 125, or 500 mg/kg/day of 318 Isthmus Furfural Extract for 90 days (Mobil, 1987). The study also found no significant difference in the number of micronucleated PCEs of the 318 Isthmus Furfural Extract-treated animals in comparison to each other or to the negative controls. 318 Isthmus Furfural Extract was not cytotoxic to red blood cell formation nor did it induce significant increase in the formation of micronucleated PCEs or NCEs in bone marrow of treated rats. 318 Isthmus Furfural Extract does not cause chromosome damage to rats dermally exposed.
In the second study, rats were orally exposed by gavage to 125, or 500 mg/kg/day of 318 Isthmus Furfural Extract for 90 days (Mobil, 1987). Additionally, the study found no significant difference in the number of micronucleated PCEs of the 318 Isthmus Furfural Extract-treated animals in comparison to each other or to the negative controls. 318 Isthmus Furfural Extract was not cytotoxic to red blood cell formation nor did it induce significant increase in the formation of micronucleated PCEs or NCEs in bone marrow of treated rats. 318 Isthmus Furfural Extract does not cause chromosome damage to rats orally exposed.
Justification for Read Across
DAE is produced as a by product in the refining of lubricating oil base stocks and waxes. Straight run vacuum distillates are extracted with solvents such as furfural, phenol, or N-methyl-2-pyrrolidone to selectively remove the undesirable polycyclic aromatic compounds, (especially 3-7 fused ring structures). DAE can be considered “worst case” by comparison to unrefined/acid treated oils, in that the extract contains higher concentrations of biologically active components (poly aromatic hydrocarbons) than the unrefined/acid treated oils. Since unrefined/acid treated oils produce positive results in the in vitro modified assay there is no reason to expect that DAE would not.
Justification for classification or non-classification
Some oil products containing relatively high concentrations of polycyclic aromatic compounds (PAC) are considered genotoxic carcinogens, and, consequently, are classified and labelled as Carcinogenic, Cat. 1B (H350) according to the EU CLP Regulation (EC No. 1272/2008). This classification as carcinogenic does not automatically imply that these substances need also to be classified as mutagenic as defined by CLP. The EU legislation aims primarily to classify substances as mutagenic if there is evidence of producing heritable genetic damage, i. e. evidence of producing mutations that are transmitted to the progeny or evidence of producing somatic mutations in combination with evidence of the substance or relevant metabolite reaching the germ line cells in the reproductive organs. The PAC in oil products are poorly bioavailable due to their physico-chemical properties (low water solubility and high molecular weight), making it unlikely that the genotoxic constituents can reach and cause damage to germ cells (Roy, 2007; Potter, 1999). Considering their poor bioavailability, oil products which have been classified as carcinogenic do not need to be classified as mutagenic unless there is clear evidence that germ cells are affected by exposure, consistent with CLP. For example, based on two in vivo micronucleus assays, one via oral exposure and the other via dermal exposure, both of which were negative, distillate aromatic extracts are unlikely to be mutagenic under in vivo conditions and do not meet the criteria for classification and labelling as mutagenic under the EU CLP Regulation (EC No. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.